A new research program to create ricin-free
castor plants was announced today by
Arcadia Biosciences, a
privately held agricultural biotechnology company, in
conjunction with Anawah, Inc.
(formerly Tilligen, Inc.). This research program will identify
and turn-off the genes in castor plants that produce ricin, a
highly toxic protein for which there is no known antidote.
Castor seed is the source of castor oil, a
unique non-toxic ingredient used in the production of nylon,
paints, lubricants, plastics and cosmetics. As castor seed is
processed to make oil, the ricin remains in the protein meal
by-product, not in the oil. Because it is toxic, the meal has no
value and must be destroyed or detoxified.
Ricin is classified as a Class B bioterrorism
agent by the Centers for Disease Control and Prevention (CDC),
according to George Saperstein, DVM, chairman of the Department
of Environmental and Population Health at Tufts University
School of Veterinary Medicine in North Grafton, Mass. Saperstein
believes ricin received this classification "because very low
doses are extremely toxic and the toxin can be aerosolized."
"There is evidence that the Iraqi government
grew large quantities of castor plants next to one of their
biological weapons laboratories," stated Jonathan Tucker, a
chemical and biological weapons expert at the Chemical and
Biological Weapons Nonproliferation Program at the Monterey
Institute of International Studies in Monterey, California. "I
doubt they were growing the castor plants for agricultural
purposes. They wanted to harvest the beans to extract ricin. We
also know that Iran has imported large quantities of castor
beans."
On two occasions, right wing extremists in the
U.S. have attempted to use ricin as a bioterrorism weapon, which
is quite easy to do, according to Tucker. Carpet cleaners with a
little knowledge about solvents who were members of the
Minnesota Patriots Council were able to extract ricin from
castor beans and conspired to use the poison to assassinate
local and federal law enforcement officials. Additionally, the
Bulgarian Secret Service used ricin to assassinate a dissident
in London and attempted another assassination in Paris.
Worldwide demand for castor oil is 1 billion
pounds annually, with an economic value in excess of $500
million. Most of the world’s supply is produced in India, China
and Brazil. The U.S. consumes more than 10 percent of world
castor oil production, yet produces very little because of
serious safety concerns. The harvesting and processing of castor
seed and meal results in numerous accidental deaths each year.
Arcadia Biosciences’ (Arcadia) project partner
is Anawah, Inc., of Seattle, Washington. Anawah’s proprietary
technology enables the development and rapid screening of
desirable mutations in genes responsible for ricin production.
"Ricin-free castor varieties address a
significant national security issue," said Roy Hodges, Arcadia’s
president and CEO. "In addition, these plants will create
considerable new economic opportunity for farmers and processors
in the U.S. and elsewhere, as meal from ricin-free castor could
be utilized as a protein source for animal feeds, increasing the
value of the crop"
Ken Hunt, president & CEO of Anawah, Inc., said,
"Ricin-free castor has long been an unrealized objective of the
oilseed industry. Our technology will enable us to target all
genes responsible for ricin production and effectively eliminate
expression of ricin in castor seeds".
Arcadia Biosciences, based in Phoenix,
Arizona, is an agricultural biotechnology company that develops
and acquires technologies to make agriculture more economically
and environmentally sustainable. Arcadia is a wholly owned
subsidiary of Exeter Life Sciences, Inc., a multidisciplinary
company with operating units addressing market opportunities in
human, animal and plant health.
Anawah, based in Seattle, Washington, and
Davis, California is a research and development company focused
on discovering and developing superior genetic traits in plants
and animals, including fish. Anawah integrates powerful,
proprietary, high throughput genetic screening technologies,
broad breeding expertise and state-of-the-art advances in
molecular biology and genomics.